Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialization of medical imaging and data, management software solutions for world-wide healthcare enterprises. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.
1977
102
LTM Revenue $22.1M
LTM EBITDA -$1.0M
$43.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mach7 Technologies has a last 12-month revenue (LTM) of $22.1M and a last 12-month EBITDA of -$1.0M.
In the most recent fiscal year, Mach7 Technologies achieved revenue of $11.1M and an EBITDA of -$9.7M.
Mach7 Technologies expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Mach7 Technologies valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $22.1M | XXX | $11.1M | XXX | XXX | XXX |
Gross Profit | $20.8M | XXX | $10.2M | XXX | XXX | XXX |
Gross Margin | 94% | XXX | 92% | XXX | XXX | XXX |
EBITDA | -$1.0M | XXX | -$9.7M | XXX | XXX | XXX |
EBITDA Margin | -5% | XXX | -87% | XXX | XXX | XXX |
EBIT | -$5.5M | XXX | -$14.4M | XXX | XXX | XXX |
EBIT Margin | -25% | XXX | -130% | XXX | XXX | XXX |
Net Profit | -$4.0M | XXX | -$5.1M | XXX | XXX | XXX |
Net Margin | -18% | XXX | -46% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Mach7 Technologies's stock price is AUD 0 (or $0).
Mach7 Technologies has current market cap of AUD 89.3M (or $57.3M), and EV of AUD 66.9M (or $43.0M).
See Mach7 Technologies trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$43.0M | $57.3M | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Mach7 Technologies has market cap of $57.3M and EV of $43.0M.
Mach7 Technologies's trades at 2.6x EV/Revenue multiple, and -8.1x EV/EBITDA.
Equity research analysts estimate Mach7 Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mach7 Technologies has a P/E ratio of -14.3x.
See valuation multiples for Mach7 Technologies and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $57.3M | XXX | $57.3M | XXX | XXX | XXX |
EV (current) | $43.0M | XXX | $43.0M | XXX | XXX | XXX |
EV/Revenue | 1.9x | XXX | 2.6x | XXX | XXX | XXX |
EV/EBITDA | -41.3x | XXX | -8.1x | XXX | XXX | XXX |
EV/EBIT | -7.9x | XXX | -4.4x | XXX | XXX | XXX |
EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
P/E | -14.3x | XXX | -12.7x | XXX | XXX | XXX |
EV/FCF | 478.9x | XXX | 43.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMach7 Technologies's last 12 month revenue growth is 17%
Mach7 Technologies's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Mach7 Technologies's rule of 40 is -45% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mach7 Technologies's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mach7 Technologies and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 17% | XXX | 30% | XXX | XXX | XXX |
EBITDA Margin | -5% | XXX | -32% | XXX | XXX | XXX |
EBITDA Growth | -161% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | -45% | XXX | -14% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 221% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mach7 Technologies acquired XXX companies to date.
Last acquisition by Mach7 Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Mach7 Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Mach7 Technologies founded? | Mach7 Technologies was founded in 1977. |
Where is Mach7 Technologies headquartered? | Mach7 Technologies is headquartered in Australia. |
How many employees does Mach7 Technologies have? | As of today, Mach7 Technologies has 102 employees. |
Is Mach7 Technologies publicy listed? | Yes, Mach7 Technologies is a public company listed on ASX. |
What is the stock symbol of Mach7 Technologies? | Mach7 Technologies trades under M7T ticker. |
When did Mach7 Technologies go public? | Mach7 Technologies went public in 2005. |
Who are competitors of Mach7 Technologies? | Similar companies to Mach7 Technologies include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Mach7 Technologies? | Mach7 Technologies's current market cap is $57.3M |
What is the current revenue of Mach7 Technologies? | Mach7 Technologies's last 12 months revenue is $22.1M. |
What is the current revenue growth of Mach7 Technologies? | Mach7 Technologies revenue growth (NTM/LTM) is 17%. |
What is the current EV/Revenue multiple of Mach7 Technologies? | Current revenue multiple of Mach7 Technologies is 1.9x. |
Is Mach7 Technologies profitable? | Yes, Mach7 Technologies is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Mach7 Technologies? | Mach7 Technologies's last 12 months EBITDA is -$1.0M. |
What is Mach7 Technologies's EBITDA margin? | Mach7 Technologies's last 12 months EBITDA margin is -5%. |
What is the current EV/EBITDA multiple of Mach7 Technologies? | Current EBITDA multiple of Mach7 Technologies is -41.3x. |
What is the current FCF of Mach7 Technologies? | Mach7 Technologies's last 12 months FCF is $0.1M. |
What is Mach7 Technologies's FCF margin? | Mach7 Technologies's last 12 months FCF margin is 0%. |
What is the current EV/FCF multiple of Mach7 Technologies? | Current FCF multiple of Mach7 Technologies is 478.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.